NBIX vs RPTX · P/E 45, rev $1.77B vs $61.8M cap
Neurocrine Biosciences Inc (NBIX) versus Repare Therapeutics Inc (RPTX) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Repare Therapeutics Inc (RPTX) is a biotechnology company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
RPTX does not have a complete income-statement cache yet.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. RPTX currently screens at market cap $61.8M.
Not investment advice. Open the NBIX and RPTX stock pages for the full models.
Not investment advice.